Tumor selective uptake of drug-nanodiamond complexes improves therapeutic outcome in pancreatic cancer

Vijay S. Madamsetty, Anil Sharma, Maria Toma, Stefanie Samaniego, Audrey Gallud, Enfeng Wang, Krishnendu Pal, Debabrata Mukhopadhyay, Bengt Fadeel

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer-related deaths and novel treatment approaches are urgently needed. Here we show that poly(ethylene glycol)-functionalized nanodiamonds loaded with doxorubicin (ND-PEG-DOX) afforded a considerable improvement over free drug in an orthotopic pancreatic xenograft model. ND-PEG-DOX complexes were also superior to free DOX in 3-dimensional (3D) tumor spheroids of PDAC. ND-PEG showed no cytotoxicity towards macrophages, and histopathological analysis showed no abnormalities of major organs upon in vivo administration of ND-PEG-DOX. These results provide evidence that ND-mediated drug delivery may serve as a means of improving the therapeutic outcome in PDAC.

Original languageEnglish (US)
Pages (from-to)112-121
Number of pages10
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Volume18
DOIs
StatePublished - Jun 1 2019

Fingerprint

Nanodiamonds
Pancreatic Neoplasms
Polyethylene glycols
Tumors
Adenocarcinoma
Pharmaceutical Preparations
Neoplasms
Ethylene Glycol
Heterografts
Doxorubicin
Therapeutics
Macrophages
Cytotoxicity
Drug delivery

Keywords

  • Drug delivery
  • Nanodiamonds
  • Nanomedicine
  • Pancreatic adenocarcinoma

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Molecular Medicine
  • Biomedical Engineering
  • Materials Science(all)
  • Pharmaceutical Science

Cite this

Tumor selective uptake of drug-nanodiamond complexes improves therapeutic outcome in pancreatic cancer. / Madamsetty, Vijay S.; Sharma, Anil; Toma, Maria; Samaniego, Stefanie; Gallud, Audrey; Wang, Enfeng; Pal, Krishnendu; Mukhopadhyay, Debabrata; Fadeel, Bengt.

In: Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 18, 01.06.2019, p. 112-121.

Research output: Contribution to journalArticle

Madamsetty, Vijay S. ; Sharma, Anil ; Toma, Maria ; Samaniego, Stefanie ; Gallud, Audrey ; Wang, Enfeng ; Pal, Krishnendu ; Mukhopadhyay, Debabrata ; Fadeel, Bengt. / Tumor selective uptake of drug-nanodiamond complexes improves therapeutic outcome in pancreatic cancer. In: Nanomedicine: Nanotechnology, Biology, and Medicine. 2019 ; Vol. 18. pp. 112-121.
@article{ba71052679584ee0834e1ebe8777547e,
title = "Tumor selective uptake of drug-nanodiamond complexes improves therapeutic outcome in pancreatic cancer",
abstract = "Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer-related deaths and novel treatment approaches are urgently needed. Here we show that poly(ethylene glycol)-functionalized nanodiamonds loaded with doxorubicin (ND-PEG-DOX) afforded a considerable improvement over free drug in an orthotopic pancreatic xenograft model. ND-PEG-DOX complexes were also superior to free DOX in 3-dimensional (3D) tumor spheroids of PDAC. ND-PEG showed no cytotoxicity towards macrophages, and histopathological analysis showed no abnormalities of major organs upon in vivo administration of ND-PEG-DOX. These results provide evidence that ND-mediated drug delivery may serve as a means of improving the therapeutic outcome in PDAC.",
keywords = "Drug delivery, Nanodiamonds, Nanomedicine, Pancreatic adenocarcinoma",
author = "Madamsetty, {Vijay S.} and Anil Sharma and Maria Toma and Stefanie Samaniego and Audrey Gallud and Enfeng Wang and Krishnendu Pal and Debabrata Mukhopadhyay and Bengt Fadeel",
year = "2019",
month = "6",
day = "1",
doi = "10.1016/j.nano.2019.02.020",
language = "English (US)",
volume = "18",
pages = "112--121",
journal = "Nanomedicine: Nanotechnology, Biology, and Medicine",
issn = "1549-9634",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Tumor selective uptake of drug-nanodiamond complexes improves therapeutic outcome in pancreatic cancer

AU - Madamsetty, Vijay S.

AU - Sharma, Anil

AU - Toma, Maria

AU - Samaniego, Stefanie

AU - Gallud, Audrey

AU - Wang, Enfeng

AU - Pal, Krishnendu

AU - Mukhopadhyay, Debabrata

AU - Fadeel, Bengt

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer-related deaths and novel treatment approaches are urgently needed. Here we show that poly(ethylene glycol)-functionalized nanodiamonds loaded with doxorubicin (ND-PEG-DOX) afforded a considerable improvement over free drug in an orthotopic pancreatic xenograft model. ND-PEG-DOX complexes were also superior to free DOX in 3-dimensional (3D) tumor spheroids of PDAC. ND-PEG showed no cytotoxicity towards macrophages, and histopathological analysis showed no abnormalities of major organs upon in vivo administration of ND-PEG-DOX. These results provide evidence that ND-mediated drug delivery may serve as a means of improving the therapeutic outcome in PDAC.

AB - Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer-related deaths and novel treatment approaches are urgently needed. Here we show that poly(ethylene glycol)-functionalized nanodiamonds loaded with doxorubicin (ND-PEG-DOX) afforded a considerable improvement over free drug in an orthotopic pancreatic xenograft model. ND-PEG-DOX complexes were also superior to free DOX in 3-dimensional (3D) tumor spheroids of PDAC. ND-PEG showed no cytotoxicity towards macrophages, and histopathological analysis showed no abnormalities of major organs upon in vivo administration of ND-PEG-DOX. These results provide evidence that ND-mediated drug delivery may serve as a means of improving the therapeutic outcome in PDAC.

KW - Drug delivery

KW - Nanodiamonds

KW - Nanomedicine

KW - Pancreatic adenocarcinoma

UR - http://www.scopus.com/inward/record.url?scp=85063594526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063594526&partnerID=8YFLogxK

U2 - 10.1016/j.nano.2019.02.020

DO - 10.1016/j.nano.2019.02.020

M3 - Article

VL - 18

SP - 112

EP - 121

JO - Nanomedicine: Nanotechnology, Biology, and Medicine

JF - Nanomedicine: Nanotechnology, Biology, and Medicine

SN - 1549-9634

ER -